| CPC A61M 5/1454 (2013.01) [A61M 5/14216 (2013.01); A61M 5/14248 (2013.01); A61M 5/145 (2013.01); A61M 5/1452 (2013.01); A61M 5/1456 (2013.01); A61M 5/158 (2013.01); A61M 2005/1402 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/14506 (2013.01); A61M 5/14566 (2013.01); A61M 2005/1585 (2013.01); A61M 5/162 (2013.01); A61M 5/168 (2013.01); A61M 5/16804 (2013.01); A61M 5/1684 (2013.01); A61M 5/1685 (2013.01); A61M 5/16877 (2013.01); A61M 5/1723 (2013.01); A61M 2205/18 (2013.01); A61M 2205/276 (2013.01); A61M 2205/33 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01)] | 20 Claims |

|
1. A wearable drug delivery device comprising:
an outer housing attachable to a patient;
a drug storage container positioned at least partially within the outer housing;
an insertion mechanism positioned at least partially within the outer housing and including:
an insertion mechanism housing,
a rotational biasing member configured to rotate the insertion mechanism housing, and
a delivery member connected or configured to be connected in fluid communication with the drug storage container and configured for insertion into the patient;
a retainer selectively moveable with respect to the insertion mechanism housing, the retainer having a first position wherein the retainer is operably coupled with the insertion mechanism housing to prevent rotation of the insertion mechanism housing and a second position wherein the retainer is at least temporarily uncoupled from the insertion mechanism housing to allow rotation of the insertion mechanism housing; and
wherein at least a portion of the delivery member is initially disposed within the insertion mechanism housing.
|